DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

Octubre 04, 2018
|
Share Article
|
Download Press Release
For Immediate Release
Contact: DEA Public Affairs
Phone Number: (571) 776-2508

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and develop positive solutions to the issues these providers often face.

“DEA views the nearly 1.8 million registrants across the country as our partners and it is our duty and obligation to ensure their voices are heard,” said John J. Martin, DEA Deputy Administrator who heads the Office of Diversion Control Division. “Part of DEA’s regulatory and enforcement responsibilities must include productive, ongoing dialogue with these provider groups. These efforts improve our transparency, increase communication and help law enforcement understand the many challenges these providers face.”

The groups attending today’s listening session include:

  • American Medical Association
  • American Psychiatric Association
  • American Academy of Family Physicians
  • American Academy of Physician Assistants
  • American Association of Nurse Practitioners
  • American Society of Addiction Medicine
  • American Academy of Pain Medicine
  • National Association of Community Health Centers
  • American Pharmacists Association
  • American College of Emergency Physicians
  • National Council for Behavioral Health
  • Federation of State Medical Boards

Today’s meeting continues DEA’s aggressive outreach to heath care providers, registrants, pharmacy groups, and many others who have partnered with law enforcement in addressing critical issues such as the nationwide opioid epidemic. DEA regularly hosts Practitioner Diversion Awareness Conferences around the country to educate doctors, nurse practitioners, pharmacists and other medical professionals on proper prescribing and their critical role as registrants in protecting the public and fulfilling their critical duties as part of the Controlled Substances Act.

###

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

@DEAHQ
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español